Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

9.500 -0.330 (-3.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Vir Biotechnology Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics ↗
As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other... 
Via Benzinga
News headline image
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 as Therapies for Chronic Hepatitis B and Hepatitis D
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
What 8 Analyst Ratings Have To Say About Vir Biotechnology ↗
 
Via Benzinga
News headline image
Where Vir Biotechnology Stands With Analysts ↗
 
Via Benzinga
News headline image
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023
– Data support the potential impact of VIR-2218 and VIR-3434 in addressing both HBV and HDV and underscore the Company’s confidence in its approach to a functional cure for HBV – 
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake ↗
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the 
Via Benzinga
News headline image
Vir Biotechnology to Host a Virtual-Only 2023 Annual Meeting of Stockholders
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
7 Top-Rated Stocks That Will Boost Your Portfolio in 2023 ↗
For those seeking to rise above the muck in a big way, these top-rated stocks to buy might accomplish just that. 
Via InvestorPlace
News headline image
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns ↗
The World Health Organization ended the global emergency 
Via Benzinga
News headline image
The 7 Best Bargain Stocks to Buy for May 2023 ↗
With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly. 
Via InvestorPlace
News headline image
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Vir Biotechnology to Participate in the BofA Securities 2023 Health Care Conference
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Why Shares of Keros Therapeutics Jumped This Week ↗
The company appointed a new director and an analyst reiterated his position on the stock. 
Via The Motley Fool
News headline image
Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments ↗
The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a... 
Via Benzinga
News headline image
7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
Via InvestorPlace
News headline image
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information ↗
 
Via Benzinga
News headline image
Biotech Stocks And The SVB Collapse — Here's What We Know ↗
The collapse of SVB will have a big impact on early-stage, venture-backed companies. 
Via Investor's Business Daily
News headline image
Vir Biotechnology to Participate in the Barclays Global Healthcare Conference
From Vir Biotechnology, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023 ↗
 
Via Benzinga
News headline image
Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results ↗
Vir Biotechnology, Inc. (NASDAQ: VIR) reported worse-than-expected Q4 results. Vir Biotechnology posted a Q4 loss of $0.76 per share, versus market expectations of $0.39 per share. The company’s... 
Via Benzinga
News headline image
The Top 7 Growth Stocks in Biotech ↗
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. 
Via InvestorPlace
News headline image
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
From Vir Biotechnology, Inc.
Via GlobeNewswire
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.